Evidence map›Paper›PMID 31852470›Full record

ArticleBMC public health2019

Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting.

Fiona Ecarnot, Gaetano Crepaldi, Philippe Juvin, John Grabenstein, Giuseppe Del Giudice, Litjen Tan, Susan O'Dwyer, Susanna Esposito, Xavier Bosch, Gaetan Gavazzi and 10 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Longitudinal Pathways to Influenza Vaccination Vary With Socio-Structural Disadvantages.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 8 countries.

Fiona EcarnotEA3920, University of Franche-Comté, Besancon, France. Fiona.ecarnot@Univ-fcomte.fr.ORCID http://orcid.org/0000-0002-4224-9731
Gaetano CrepaldiUniversity of Padua, Padua, Italy.
Philippe JuvinGlobal Product Quality Management, Sanofi Pasteur, Lyon, France.
John GrabensteinExecutive Director, Global Vaccines Medical Affairs, Merck Research Laboratories, North Wales, PA 19454, USA.
Giuseppe Del GiudiceTranslational Science Leader, R&D Center Italy, GSK Vaccines Srl, 53100, Siena, Italy.
Litjen TanChief Strategy Officer, Immunization Action Coalition, United States; Co-Chair, National Adult and Influenza Immunization Summit, Saint Paul, MN, USA.
Susan O'DwyerBoots Retail (Ireland) Limited, Nangor Road, Clondalkin, Dublin, 12, Ireland.
Susanna EspositoPediatric Clinic, Department of Biomedical and Surgical Sciences, Università degli Studi di Perugia, Perugia, Italy.
Xavier BoschCatalan Institute of Oncology, Cancer Epidemiology Research Program, L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain.
Gaetan GavazziUniversity of Grenoble-Alpes, GREPI, FRE 3405 CNRS and University Clinic of Geriatric Medicine, University hospital of Grenoble, Grenoble, France.
John PapastergiouLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
Jacques GaillatCentre Hospitalier Annecy-Genevois, Annecy, France.
Robert JohnsonHon. Senior Research Fellow, Faculty of Health Sciences: Emeritus Consultant in Pain Medicine, University of Bristol, Bristol, UK.
Marco FonzoDCTV - Department of Cardiac, Thoracic and Vascular Sciences, Hygiene and Public Health Unit, University of Padua, Padua, Italy.
Andrea RossaneseCentre for Tropical Diseases, "Sacro Cuore - Don Calabria" Hospital, Negrar, Verona, Italy.
Caterina SuitnerDepartment of Developmental and Social Psychology, University of Padova, Padova, Italy.
Jane BarrattInternational Federation on Ageing, Toronto, Ontario, Canada.
Alberta di PasqualeGSK, Wavre, Belgium.
Stefania MaggiCNR, Institute of Neuroscience - Aging Branch, Padua, Italy.
Jean-Pierre MichelUniversity of Geneva, Geneva, Switzerland.
University of Padua · ITCentre Hospitalier Annecy Genevois · FRCentre Hospitalier Universitaire de Besançon · FRCentre National de la Recherche Scientifique · FRGlaxoSmithKline (Belgium) · BEImmunization Action Coalition · USInstitut Català d'Oncologia · ESInternational Federation on Ageing · CAMerck & Co., Inc., Rahway, NJ, USA (United States) · USNeuroscience Institute · ITOspedale Sacro Cuore Don Calabria · ITSanofi (France) · FRToscana Life Sciences · ITUniversity of Bristol · GBUniversity of Geneva · CHUniversity of Perugia · ITUniversity of Toronto · CA

Funding

GlaxoSmithKline Unrestricted grantMerck Unrestricted grantPfizer Unrestricted grantTakeda Unrestricted
6 · The paper itself

Abstract

backgroundDespite the existence of efficacious vaccines, the burden of vaccine-preventable diseases remains high and the potential health benefits of paediatric, adolescent and adult vaccination are not being achieved due to suboptimal vaccine coverage rates. Based on emerging evidence that pharmacy-based vaccine interventions are feasible and effective, the European Interdisciplinary Council for Ageing (EICA) brought together stakeholders from the medical and pharmacy professions, the pharmaceutical industry, patient/ageing organisations and health authorities to consider the potential for pharmacy-based interventions to increase vaccine uptake. We report here the proceedings of this 3-day meeting held in March 2018 in San Servolo island, Venice, Italy, focussing firstly on examples from countries that have introduced pharmacy-based vaccination programmes, and secondly, listing the barriers and solutions proposed by the discussion groups.

conclusionsA range of barriers to vaccine uptake have been identified, affecting all target groups, and in various countries and healthcare settings. Ease of accessibility is a potentially modifiable determinant in vaccine uptake, and thus, improving the diversity of settings where vaccines can be provided to adults, for example by enabling community pharmacists to vaccinate, may increase the number of available opportunities for vaccination.

Indexed as

PharmacistsAdultCongresses as TopicEuropeFemaleHealth PromotionHumansItalyMaleMiddle AgedOrganizational ObjectivesPatient Acceptance of Health CarePharmaceutical ServicesProfessional RoleVaccinationPharmacistsPharmacy-based interventionsVaccinationVaccine coverage

Identifiers

PMID31852470
PMCPMC6921486
OpenAlexW2996251072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.